Does haste make waste? Prevalence and types of errors reported after publication of studies of COVID-19 therapeutics.

ABSTRACT:

Background

The COVID-19 pandemic spurred publication of a rapid proliferation of studies on potential therapeutic agents. While important for the advancement of clinical care, pressure to collect, analyze, and report data in an expedited manner could potentially increase the rate of important errors, some of which would be captured in published errata. We hypothesized that COVID-19 therapeutic studies published in the early years of the pandemic would be associated with a high rate of published errata and that, within these errata, there would be a high prevalence of serious errors.

Methods

We performed a review of published errata associated with empirical studies of COVID-19 treatments. Errata were identified via a MEDLINE and Embase search spanning January 2020 through Se

SUBMITTER: Chatterton B 

PROVIDER: S-EPMC10652527 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature